ULTRAGENYX EUROPE GMBH
502078-5456InactiveAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Oversikt
- 1–4
- Ansatte
- Ukjent
- Omsetning
- 2022
- Grunnlagt
Nøkkelbeslutningstakere
Emil D. Kakkis
Chief Executive Officer and President
Beskrivelse
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- Utländsk juridisk person
- MVA-nummer
- SE502078545601
Beslutningstakere
1 kontakter i FunnelfeedrEmil D. Kakkis
Chief Executive Officer and President
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrBridgeBio International GmbH
1–4 ansatteDeveloping transformative medicines for rare genetic conditions quickly.
SAREPTA THERAPEUTICS, INC.
0 ansatteEngineering precision genetic medicine to rescue lives from rare diseases.
OxThera Intellectual Property AB
0 ansatteDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Orchard Therapeutics (Sweden) AB
1–4 ansatteDeveloping life-transforming HSC gene therapies for severe genetic diseases.
AMICUS THERAPEUTICS LTD
1–4 ansatteGlobal biotechnology company developing transformative medicines for rare diseases.
Spørsmål om ULTRAGENYX EUROPE GMBH
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo